Skip to content
OKBio
  • Bio in Oklahoma
  • Member Benefits
  • Contact
  • Media
  • Career Center
Menu
  • Bio in Oklahoma
  • Member Benefits
  • Contact
  • Media
  • Career Center
Search

OSU research gets attention

Get in Touch

By Lillie-Beth Brinkman
Copyright (©) 2015, The Oklahoma Publishing Company

At the BIO Convention, Oklahoma State University’s tech transfer office is pitching several projects from its research scientists for possible commercialization.

Two of them are particularly close to being ready for business partners, said Scott Davis, a licensing associate with OSU’s Technology Development Center.

First, a vaccine for respiratory syncytial virus (RSV) being developed by Tom Oomens in OSU’s Center for Respiratory and Infectious Diseases is nearly finished with animal testing, Davis said. So far, data is showing the vaccine to be safe and effective.

At BIO, Davis has received significant interest from at least one pharmaceutical company for the work being done by Oomens.

Another medical breakthrough for which Davis is seeking collaborators involves the work of food microbiologist Divya Jaroni, an assistant professor of animal science at OSU whose work would help fight certain bacteria that cause food poisoning.

A company has expressed interest in collaborating with her, Davis said.

 

Author

  • admin

    View all posts

More News

OKBio

Oklahoma City Office

840 Research Parkway, Suite 250
OKC, OK 73104
+1 (405) 235.2305

Tulsa Office

100 S. Cincinnati Ave – Suite 514
Tulsa, OK 74103
+1 (918) 582.5592

  • OKBio Home
  • BIO In Oklahoma
  • Member Benefits
  • Contact
  • Media
  • Career Center

© 2022 OKBio

Follow us:

Facebook Twitter
OKBio

Programs

  • BIO In Oklahoma
  • Member Benefits
  • Contact
  • Media
  • Career Center

Services